Drugs / Fufang E'Jiao Jiang
Fufang E'Jiao Jiang
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07157748 | Dec 2025 → Jun 2027 expected | — | Third Military Medical University | Not yet recruiting | No outcome recorded |
| — | NCT04147312 | Oct 2019 → May 2021 | myalgic encephalomeyelitis/chronic fatigue syndrome | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fufang E'Jiao Jiang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04147312 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Fufang E'Jiao Jiang (FFEJJICRF) is a commonly-used Chinese patent medicine” NCT04147312 ↗ |
| Route | Oral | “20 mL orally three times daily for 90 days” NCT07157748 ↗ |